The present invention relates to isolated nucleic acid molecule encoding the transcription regulator DC- SCRIPT or a derivative thereof . The invention further relates to its use in therapy and to compound for interfering with the biological function of the transcription factor DC-SCRIPT. Such compounds can be compounds interfering with expression of DC-SCRIPT; or compounds interfering with binding of DC- SCRIPT to DNA.
